Tag: NYSE:HNT

Finance

Healthcare Touched New Highs: Taro Pharmaceutical Industries (NYSE:TARO), Inogen (NASDAQ:INGN), Health Net (NYSE:HNT)

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) continued to lead the category in 2013 with a retail value share of 25% thanks to brands such as Tarodent and Anadent, which held shares of 22% and 3%, respectively. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) stock performance was 16.65% in last session and finished the day at $137.97. Traded volume was 227,446.00million shares in the last session and the average … Continue reading Healthcare Touched New Highs: Taro Pharmaceutical Industries (NYSE:TARO), Inogen (NASDAQ:INGN), Health Net (NYSE:HNT)

John Bellich
Stock Movers

Health Net (NYSE:HNT) Reaffirms Guidance; Perfect World (NASDAQ:PWRD), Wright Medical Group Inc. (NASDAQ:WMGI), Douglas Dynamics (NYSE:PLOW)

Health Net (NYSE:HNT), a managed care company, disclosed in a regulatory filing Monday that it will be reaffirming its earnings guidance for fiscal 2014 at the Barclays Global Healthcare Conference on Tuesday. The company had previously said that it is expecting fiscal 2014 earnings of at least $3.00 per share and revenue of $14.4 billion. Analysts polled by Capital IQ are expecting EPS of $2.39 … Continue reading Health Net (NYSE:HNT) Reaffirms Guidance; Perfect World (NASDAQ:PWRD), Wright Medical Group Inc. (NASDAQ:WMGI), Douglas Dynamics (NYSE:PLOW)

Mark DeFrance